Valeant Pharma (VRX) Holder John Paulson Sold Almost 1M Shares
In an amended 13D filing on Valeant Pharma (NYSE: VRX), John Paulson's Paulson & Co. disclosed it sold 974,365 shares on 08/09 at $14.66.
The firm continues to own 20,839,035 shares, or 6%.
Paulson & Co said the sales are due to rebalancing of our portfolios based on asset flows and represent approximately 4.5% of the Reporting Person's Common Stock holding.